87 related articles for article (PubMed ID: 12152666)
41. On the mechanism of the reaction between human alpha 2-antiplasmin and plasmin.
Wiman B; Collen D
J Biol Chem; 1979 Sep; 254(18):9291-7. PubMed ID: 158022
[No Abstract] [Full Text] [Related]
42. Effect of ACE inhibition on the fibrinolytic system in patients requiring coronary artery bypass grafting.
Walter T; Szabo S; Kazmaier S; Suselbeck T; Borggrefe M; Hoffmeister HM
Thorac Cardiovasc Surg; 2009 Sep; 57(6):368-71. PubMed ID: 19707983
[TBL] [Abstract][Full Text] [Related]
43. Elevation of plasma TGF-beta1 during radiation therapy predicts radiation-induced lung toxicity in patients with non-small-cell lung cancer: a combined analysis from Beijing and Michigan.
Zhao L; Wang L; Ji W; Wang X; Zhu X; Hayman JA; Kalemkerian GP; Yang W; Brenner D; Lawrence TS; Kong FM
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1385-90. PubMed ID: 19231104
[TBL] [Abstract][Full Text] [Related]
44. Steep dose-response relationship for stage I non-small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy.
Onimaru R; Fujino M; Yamazaki K; Onodera Y; Taguchi H; Katoh N; Hommura F; Oizumi S; Nishimura M; Shirato H
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):374-81. PubMed ID: 18029106
[TBL] [Abstract][Full Text] [Related]
45. Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy.
Piotrowski T; Matecka-Nowak M; Milecki P
Neoplasma; 2005; 52(1):56-62. PubMed ID: 15739028
[TBL] [Abstract][Full Text] [Related]
46. Differential binding of plasminogen, plasmin, and angiostatin4.5 to cell surface beta-actin: implications for cancer-mediated angiogenesis.
Wang H; Doll JA; Jiang K; Cundiff DL; Czarnecki JS; Wilson M; Ridge KM; Soff GA
Cancer Res; 2006 Jul; 66(14):7211-5. PubMed ID: 16849568
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of platelet activation, plasma antithrombin III and alpha2-antiplasmin activities in hypertensive patients.
Tomczykowska M; Bielak J; Bodys A
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):15-20. PubMed ID: 15314952
[TBL] [Abstract][Full Text] [Related]
48. A prospective study of whether radiation pneumonitis is influenced by low-dose irradiated lung volume in primary lung cancer with chronic pulmonary disease.
Niibe Y; Hayakawa K; Masuda N; Yoshimura H
Gan To Kagaku Ryoho; 2007 Feb; 34(2):213-6. PubMed ID: 17301529
[TBL] [Abstract][Full Text] [Related]
49. Variation of alpha 2-plasmin inhibitor in patients with gastric cancer.
Kageyama T; Oyabu H; Tsumoto S; Ohshiba S
Bull Osaka Med Sch; 1984 Oct; 30(2):89-95. PubMed ID: 6571385
[No Abstract] [Full Text] [Related]
50. Antiplasmin: the forgotten serpin?
Coughlin PB
FEBS J; 2005 Oct; 272(19):4852-7. PubMed ID: 16176259
[TBL] [Abstract][Full Text] [Related]
51. Antiprotease inactivation by Salmonella enterica released from infected macrophages.
Lähteenmäki K; Kyllönen P; Partanen L; Korhonen TK
Cell Microbiol; 2005 Apr; 7(4):529-38. PubMed ID: 15760453
[TBL] [Abstract][Full Text] [Related]
52. Time course of serum cytokines in patients receiving proton or combined photon/proton beam radiation for resectable but medically inoperable non-small-cell lung cancer.
Gridley DS; Bonnet RB; Bush DA; Franke C; Cheek GA; Slater JD; Slater JM
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):759-66. PubMed ID: 15465192
[TBL] [Abstract][Full Text] [Related]
53. Prediction of radiation-induced changes in the lung after stereotactic body radiation therapy of non-small-cell lung cancer.
Kyas I; Hof H; Debus J; Schlegel W; Karger CP
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):768-74. PubMed ID: 17097829
[TBL] [Abstract][Full Text] [Related]
54. [Levels of serum soluble tumor necrosis factor receptor in patients with lung cancer].
Yan GM; Lui JY; Yang HZ
Hunan Yi Ke Da Xue Xue Bao; 2000 Oct; 25(5):515, 517. PubMed ID: 12212141
[No Abstract] [Full Text] [Related]
55. Serum levels of apoptosis biomarkers, survivin and TNF-alpha in nonsmall cell lung cancer.
Derin D; Soydinç HO; Guney N; Tas F; Camlica H; Duranyildiz D; Yasasever V; Topuz E
Lung Cancer; 2008 Feb; 59(2):240-5. PubMed ID: 17875341
[TBL] [Abstract][Full Text] [Related]
56. Results of a phase I study to dose escalate using intensity modulated radiotherapy guided by combined PET/CT imaging with induction chemotherapy for patients with non-small cell lung cancer.
Holloway CL; Robinson D; Murray B; Amanie J; Butts C; Smylie M; Chu K; McEwan AJ; Halperin R; Roa WH
Radiother Oncol; 2004 Dec; 73(3):285-7. PubMed ID: 15588872
[TBL] [Abstract][Full Text] [Related]
57. Transforming growth factor-beta plasma dynamics and post-irradiation lung injury in lung cancer patients.
Novakova-Jiresova A; Van Gameren MM; Coppes RP; Kampinga HH; Groen HJ
Radiother Oncol; 2004 May; 71(2):183-9. PubMed ID: 15110452
[TBL] [Abstract][Full Text] [Related]
58. Predicting the severity of systemic inflammatory response syndrome (SIRS)-associated coagulopathy with hemostatic molecular markers and vascular endothelial injury markers.
Iba T; Gando S; Murata A; Kushimoto S; Saitoh D; Eguchi Y; Ohtomo Y; Okamoto K; Koseki K; Mayumi T; Ikeda T; Ishhikura H; Ueyama M; Ogura Y; Endo S; Shimazaki S;
J Trauma; 2007 Nov; 63(5):1093-8. PubMed ID: 17993956
[TBL] [Abstract][Full Text] [Related]
59. [Clinical study of hemostatic coagulation markers in prethrombosis state of pregnancy induced hypertension].
Shi Q; Chen C; Wang XF; Wang HL
Zhonghua Fu Chan Ke Za Zhi; 2004 Nov; 39(11):733-6. PubMed ID: 15634496
[TBL] [Abstract][Full Text] [Related]
60. On the structure of the stable complex between plasmin and alpha-2-antiplasmin.
Nilsson T; Wiman B
FEBS Lett; 1982 Jun; 142(1):111-4. PubMed ID: 6213426
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
